Amryt Pharma plc — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$222.5M

Net Income/Loss (FY2021)

$1.0M

Total Assets (FY2021)

$816.1M

Total Equity (FY2021)

$356.7M

Cash Flows from Operating Activities (FY2021)

$15.5M

Source: Amryt Pharma plc 20-F filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.